First Tracks Biotherapeutics (TRAX) — Defensive Interval Ratio
First Tracks Biotherapeutics (TRAX) has a Defensive Interval Ratio of 419 days as of March 2026. Defensive assets of $37.99 Million (cash $-, short-term investments $37.99 Million, receivables $-) cover 419 days of daily cash needs of $90.72K/day. See First Tracks Biotherapeutics working capital to net assets to evaluate short-term liquidity relative to the company's equity base.
Defensive Interval Ratio
Defensive Assets
Daily Cash Need
Current Liabilities
First Tracks Biotherapeutics Defensive Interval Ratio (2023–2025)
This chart shows how First Tracks Biotherapeutics's Defensive Interval Ratio has evolved across 3 annual periods from 2023 to 2025. As of March 2026, the ratio stands at 419 days, meaning defensive assets of $37.99 Million can fund 419 days of operations without new revenue. See debt-free asset ratio of First Tracks Biotherapeutics to measure how much of total assets are equity-financed.
Annual Defensive Interval Ratio for First Tracks Biotherapeutics (2023–2025)
The table below presents the year-by-year Defensive Interval Ratio for First Tracks Biotherapeutics from 2023 to 2025, covering 3 annual filings. Each row shows defensive assets, daily cash need, the DIR in days, and the change in days compared to the prior year. For live market cap and the full company financial profile, see First Tracks Biotherapeutics market capitalisation.
| Year | DIR (days) | Defensive Assets (USD) | Daily Cash Need | Cash | ST Investments | Change (days) |
|---|---|---|---|---|---|---|
| 2025 | 864 days | $73.44 Million | $84.99K/day | $- | $73.44 Million | ▼ -1782 days |
| 2024 | 2646 days | $262.29 Million | $99.13K/day | $- | $262.29 Million | ▼ -4463 days |
| 2023 | 7109 days | $354.94 Million | $49.93K/day | $- | $354.94 Million | — |